Search

everythinglearnresearchcommunity

for

Search:↓

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Minoxidil helps heart function but doesn't improve exercise ability and may cause complications.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

New treatments for male hypogonadism are effective and should be personalized.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Minoxidil, propranolol, and furosemide effectively control severe hypertension, but may cause sodium retention.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Thymosin β4 helps improve skin healing and reduce scarring.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

There is no significant link between male pattern baldness and insulin resistance.

Minoxidil may cause heart changes; use caution and monitor patients with heart conditions.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.